Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
Antiviral Therapy|December 25, 2009
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study, Julia Bohlius, Kurt Schmidlin, et al.
AIDS (London, England)|June 18, 2009
Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy, Julia Bohlius, Kurt Schmidlin, et al.
Blood|March 4, 2011
HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytesJulia Bohlius, Kurt Schmidlin, François Boué, et al.
Addiction (Abingdon, England)|May 28, 2011
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidenceKaty M E Turner, Sharon Hutchinson, Peter Vickerman, et al.
Tropical Medicine & International Health : TM & IH|April 1, 2008
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America, Olivia Keiser, Kathryn Anastos, et al.
AIDS (London, England)|May 16, 2007
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesMargaret May, Jonathan A C Sterne, Caroline Sabin, et al.
Journal of Women'S Health (2002)|February 5, 2008
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein, Andrew Boulle, Denis Nash, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsMary-Ann Davies, Margaret May, Carolyn Bolton-Moore, et al.
Lancet (London, England)|March 15, 2006
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein, Martin W G Brinkhof, François Dabis, et al.
Pageof 8